Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mini-oral Pulse Steroid Therapy with NCES for Stable Vitiligo
NCT07472816Phase 4Not yet recruiting
- Sponsor
- Cairo University
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in Vitiligo (2 arms), sponsored by Cairo University. Primary endpoints: Incidence of perilesional halo at 4 months, Percent change in VESTA score at 4 months and 1 more. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07472816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07472816.